Ventas, Inc.
NYSE:VTRREIT - Healthcare Facilities
-$0.28 today
- Market cap
- $46.64B
- Beta
- 0.73
- P/E (TTM)
- 149.7
- EPS (TTM)
- $0.55
- Dividend yield
- 2.39%
Volume 3.72M
Average 4.09M
VTR Net Receivables
Amounts owed to the company by customers and others, net of allowances for uncollectible accounts.
Ventas, Inc.NYSE: VTR
Net Receivables · Q2 FY2026 · quarter ended Jun 2026
Net receivables rises 68.5% from a year ago
Net receivables stood at $714.27M at the end of Q2 FY2026, up 68.5% from a year earlier. Over 3 fiscal years it compounded at -17.8% a year.
Context
- Net receivables amounted to 2.4% of total assets at the end of Q2 FY2026, up 0.8 pp from a year earlier.
- Net receivables increased in 2 of the last 3 fiscal years.
What to watch
Whether net receivables keeps rising in the next quarterly balance sheet after a +68.5% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Net Receivables history
USD · from the balance sheet
- Latest · FY2025
- 415.57M USD
- Year-over-year change
- +10.6%
- 4-year CAGR
- -13.0%
| Period | Period end | Net Receivables | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 415.57M | +10.6% |
| FY2024 | 2024-12-31 | 375.68M | +51.3% |
| FY2023 | 2023-12-31 | 248.25M | -66.9% |
| FY2022 | 2022-12-31 | 748.95M | +3.2% |
| FY2021 | 2021-12-31 | 726.03M | — |
Net Receivables vs competitors
How VTR compares with its peers on the latest reported figures
- VTR's Jun 2026 net receivables of $714.27M is the 3rd highest of the 11 companies compared; the peer median is $179.3M.
- Its year-over-year change of +68.5% is the 2nd highest of 11, against a peer median of -21.3%.
- Net receivables amounts to 2.4% of total assets for VTR, versus a peer median of 2.6%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Sep 2026 | $3.05B | -26.6% | +25.9% | 4.1% | |
MPTMedical Properties Trust, Inc. | Jun 2026 | $945.86M | -5.7% | -2.8% | 6.4% |
| Jun 2026 | $714.27M | +68.5% | -17.8% | 2.4% | |
| Sep 2026 | $325.91M | +1490.3% | -51.1% | 11.8% | |
| Jun 2026 | $276.09M | -86.3% | +11.0% | 2.7% | |
| Sep 2026 | $228.5M | +21.2% | +3.5% | 3.0% | |
| Jun 2026 | $130.1M | -16.1% | -9.0% | 2.4% | |
NHPNational Healthcare Properties, Inc. (NHP) | Dec 2025 | $30.74M | +7.1% | — | 1.8% |
| Sep 2026 | $23.33M | -77.9% | +527.0% | 0.3% | |
| Sep 2026 | $0 | -100.0% | +16.9% | 0.0% | |
| Sep 2026 | $0 | -100.0% | -3.0% | 0.0% | |
| Peer median (excluding VTR) | $179.3M | -21.3% | +3.5% | 2.6% | |
Competitors are the stored peer set for VTR. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | 149.73M | 122.56M | 508.79M | 897.85M | 741.07M |
| Short-term Investments | 0 | 0 | 0 | 0 | 0 |
| Net Receivables | 726.03M | 748.95M | 248.25M | 375.68M | 415.57M |
| Inventory | 0 | 0 | 0 | 0 | 0 |
| Other Current Assets | 75.27M | 93.07M | 111.16M | 78.01M | 88.06M |
| Total Current Assets | 951.02M | 964.59M | 868.2M | 1.35B | 1.33B |
| Property, Plant & Equipment (Net) | 0 | 0 | 0 | 0 | 0 |
| Goodwill | 1.05B | 1.04B | 1.05B | 1.04B | 1.05B |
| Intangible Assets | 7.27M | 6.39M | 5.58M | 11.51M | 10.68M |
| Long-term Investments | 597.07M | 675.31M | 678.52M | 721.75M | 718.19M |
| Tax Assets | 11.15M | 10.49M | 1.75M | 1.93M | 2.8M |
| Other Non-current Assets | 22.11B | 21.46B | 22.13B | 23.06B | 24.49B |
| Total Non-current Assets | 23.77B | 23.19B | 23.86B | 24.84B | 26.27B |
| Total Assets | 24.72B | 24.16B | 24.73B | 26.19B | 27.59B |
| Account Payables | 1.09B | 1.03B | 1.04B | 1.15B | 1.24B |
| Short-term Debt | 336.45M | 428.23M | 14.01M | 6.4M | 0 |
| Tax Payables | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 10.85M | 6.49M | 9.24M | 2.73M | 4.03M |
| Total Current Liabilities | 1.54B | 1.58B | 1.18B | 1.3B | 1.39B |
| Long-term Debt | 11.69B | 11.87B | 13.48B | 13.52B | 13.01B |
| Deferred Tax Liabilities | 59.26M | 35.57M | 24.5M | 8.15M | 23.41M |
| Deferred Revenue (Non-current) | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Liabilities | 280.28M | 264.65M | 302.64M | 310.23M | 375.15M |
| Total Non-current Liabilities | 12.23B | 12.36B | 14B | 14.05B | 13.62B |
| Total Liabilities | 13.77B | 13.94B | 15.18B | 15.36B | 15.01B |
| Common Stock | 99.84M | 99.91M | 100.65M | 109.12M | 118.73M |
| Retained Earnings | (4.68B) | (5.45B) | 0 | 0 | 0 |
| Accumulated OCI | (4.74B) | (5.49B) | (6.25B) | (6.92B) | (7.57B) |
| Other Stockholders Equity | 4.68B | 5.45B | 0 | 0 | 0 |
| Minority Interest | 91.38M | 68.71M | 56.35M | 58.33M | 58.56M |
| Total Equity | 10.95B | 10.22B | 9.54B | 10.83B | 12.59B |
| Total Debt | 12.22B | 12.49B | 13.69B | 13.74B | 13.22B |
| Net Debt | 12.08B | 12.36B | 13.18B | 12.84B | 12.48B |
Ventas, Inc.
NYSE:VTR
Intrinsic Alpha fair value
Locked
Current Price
$88.20
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.